SciELO - Scientific Electronic Library Online

 
vol.142 número2Obesidad y cáncer: la tormenta perfectaProceso de alta hospitalaria, revisión de la literatura índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

Compartir


Revista médica de Chile

versión impresa ISSN 0034-9887

Resumen

SUAZO, José  y  RIGOTTI, Attilio. Risk of type 2 diabetes mellitus associated with statin therapy: evidence and possible mechanisms. Rev. méd. Chile [online]. 2014, vol.142, n.2, pp.222-228. ISSN 0034-9887.  http://dx.doi.org/10.4067/S0034-98872014000200011.

In the last decade, an increased number of new cases of type 2 diabetes mellitus (T2DM) among patients who use statins have been reported. The aim of the present review is to compile the most relevant information about the risk of T2DM associated with the use and dose of different statins, especially based on meta-analysis considering different studies worldwide. To explain this relationship, several studies have reported the effect of statins on insulin resistance in dyslipidemic non-diabetic patients, reporting different findings according to the types of statins. In addition, some reports -based on culture of β pancreatic cells- have evaluated the effect of these drugs in certain cellular events that are essential for insulin secretion. Clearly, further studies in humans are needed -applying more robust tests than those used up to date- in order to define more precisely the potential mechanisms explaining the higher incidence of T2DM among statin users.

Palabras clave : Diabetes mellitus type 2; Hydroxymethylglutaryl - Co A Reductase inhibitors; Insulin resistance.

        · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons